Insider · CIK 0001181190
Glenn P Muir
director
Files at RGEN (REPLIGEN CORP), STIM (Neuronetics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | RGEN REPLIGEN CORP | MOption exercise Common Stock | +3,366 | $26.12 | $88k | 36,622 | Dec 17, 2025 |
| Dec 16, 2025 | RGEN REPLIGEN CORP | MOption exercise Stock Option (Right to Buy)derivative | +3,366 | $0.00 | $0 | 3,366 | Dec 17, 2025 |
| Oct 20, 2025 | STIM Neuronetics, Inc. | AGrant or award Common Stock | +7,554 | $0.00 | $0 | 371,816 | Oct 22, 2025 |
| May 22, 2025 | STIM Neuronetics, Inc. | AGrant or award Common Stock | +30,000 | - | - | 364,262 | May 27, 2025 |
| May 15, 2025 | RGEN REPLIGEN CORP | AGrant or award Common Stock | +973 | $0.00 | $0 | 33,256 | May 19, 2025 |
| May 15, 2025 | RGEN REPLIGEN CORP | AGrant or award Stock Option (Right to Buy)derivative | +1,800 | $0.00 | $0 | 1,800 | May 19, 2025 |
| Nov 19, 2024 | RGEN REPLIGEN CORP | MOption exercise Common Stock | +19,000 | $36.29 | $690k | 32,283 | Nov 20, 2024 |
| Nov 19, 2024 | RGEN REPLIGEN CORP | MOption exercise Stock Option (Right to Buy)derivative | -19,000 | $0.00 | $0 | 0 | Nov 20, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.